The -842G/C polymorphisms of PIN1 contributes to cancer risk: a meta-analysis of 10 case-control studies.
The -842G/C polymorphisms of PIN1 contributes to cancer risk: a meta-analysis of 10 case-control studies.
复制标题
DOI:
10.1371/journal.pone.0071516
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Li ZJ
中科院分区:
文献类型:
--
作者:
Xu HR;Xu ZF;Sun YL;Han JJ;Li ZJ
Peptidyl-prolyl cis–trans isomerase NIMA-interacting 1 (PIN1) plays an important role in cancer development. The relationship between PIN1 −842G/C (rs2233678) polymorphism and cancer risk was inconclusive according to published literature. A literature search, up to February 2013, was carried out using PubMed, EMBASE and the China National Knowledge Infrastructure (CNKI) database. A total of 10 case-control studies including 4619 cases and 4661 controls contributed to the quantitative analysis. Odds ratio (OR) and 95% confidence intervals (95% CI) were used to assess the strength of association. Overall, individuals with the variant CG (OR = 0.728, 95% CI: 0.585,0.906; Pheterogeneity<0.01) and CG/CC (OR = 0.731, 95% CI: 0.602,0.888; Pheterogeneity<0.01) genotypes were associated with a significantly reduced cancer risk compared with those with wild GG genotype. Sub-group analysis revealed that the variant CG (OR = 0.635, 95% CI: 0.548,0.735; Pheterogeneity = 0.240) and CG/CC (OR = 0.645, 95% CI: 0.559,0.744, Pheterogeneity = 0.258) genotypes still showed an reduced risk of cancer in Asians; while no significant association was observed in Caucasians (CG vs.GG: OR = 0.926, 95% CI: 0.572,1.499, Pheterogeneity<0.01; CG/CC vs. GG: OR = 0.892, 95% CI: 0.589,1.353; Pheterogeneity<0.01). Furthermore, sensitivity analysis confirmed the stability of results. Begg's funnel plot and Egger's test did not reveal any publication bias. This meta-analysis suggests that the PIN1 −842G/C polymorphism is associated with a significantly reduced risk of cancer, especially in Asian populations.
登录
查看更多内容
影响因子:
6
作者:
Bao, L;Kimzey, A;Wang, DG
通讯作者:
Wang, DG
影响因子:
3.9
作者:
Lu, Jiachun;Yang, Lei;Zhou, Yifeng
通讯作者:
Zhou, Yifeng
影响因子:
37.3
作者:
Lam PB;Burga LN;Wu BP;Hofstatter EW;Lu KP;Wulf GM
通讯作者:
Wulf GM
DOI:
10.1016/0197-2456(86)90046-2
发表时间:
1986-09-01
期刊:
CONTROLLED CLINICAL TRIALS
影响因子:
--
作者:
DERSIMONIAN, R;LAIRD, N
通讯作者:
LAIRD, N
影响因子:
5.3
作者:
Chen, SY;Wulf, G;Balk, SP
通讯作者:
Balk, SP